Fig. 14From: Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulationsPredicted boiled-egg plot provided by SwissADME for 10a–pBack to article page
